MTIC
CALT

Missouri Trust & Investment Company’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Missouri Trust & Investment Company’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35
Closed -$1.4K – 453
2024
Q3 		$1.4K Hold
35
– – ﹤0.01% 361
2024
Q2 		$1.36K Hold
35
– – ﹤0.01% 368
2024
Q1 		$735 Hold
35
– – ﹤0.01% 383
2023
Q4 		$901 Hold
35
– – ﹤0.01% 394
2023
Q3 		$639 Hold
35
– – ﹤0.01% 400
2023
Q2 		$554 Hold
35
– – ﹤0.01% 451
2023
Q1 		$839 Hold
35
– – ﹤0.01% 338
2022
Q4 		$1K Hold
35
– – ﹤0.01% 343
2022
Q3 		$1K Hold
35
– – ﹤0.01% 354
2022
Q2 		$1K Hold
35
– – ﹤0.01% 366
2022
Q1 		$1K Hold
35
– – ﹤0.01% 351
2021
Q4 		$1K Buy
+35
New +$703 ﹤0.01% 398

Missouri Trust & Investment Company's CALT Position: Q4 2024 in Review

Missouri Trust & Investment Company sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2024, closing a stake of 35 shares — an estimated $1.4K sold.

Missouri Trust & Investment Company first reported a position in CALT in Q4 2021 and held it in 12 quarters. The position peaked at $1.4K in Q3 2024. 0 funds tracked by Wall St. Rank hold CALT as of Q4 2024.

  • Missouri Trust & Investment Company reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 35 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2024, an estimated $1.4K.
  • Missouri Trust & Investment Company first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2021 and held it in 12 quarters.
  • Missouri Trust & Investment Company's Calliditas Therapeutics AB American Depositary Shares position peaked at $1.4K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2024.

Based on Missouri Trust & Investment Company's 13F filing for Q4 2024, filed 17 Jan 2025.